Richard L. Lindstrom, M.D
Director at Harrow; Director at Ocular Therapeutix; Director at LENSAR. Based in Bedford, Massachusetts.
- Rank
- 12447th of 14,452
- Companies held
- 3
- Largest holding
- HROW, 51.6% of total
- Latest SEC filing
- Jun 10, 2026
- Listed but not counted
- $839K
What the $6.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Harrow HROW Common Stock | Directly | 100,000 | $32.13 | $3.2M | 51.6% | Form 4, Sep 30, 2022 |
| Ocular Therapeutix OCUL Common Stock | Directly | 260,933 | $5.86 | $1.5M | 24.6% | Form 4, Jun 10, 2026 |
| LENSAR LNSR Common Stock | Directly | 263,831 | $4.64 | $1.2M | 19.7% | Form 4, Jun 3, 2026 |
| Ocular Therapeutix OCUL Common Stock | Through Lindstrom Family No 2 Limited Partnership | 43,559 | $5.86 | $255K | 4.1% | Form 4, Jun 11, 2025 |
Share counts are the amounts Richard L. Lindstrom, M.D reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Richard L. Lindstrom, M.D's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Harrow HROW Common Stock | Through Lindstrom Family Limited Partnership Held by a company or fund the insider manages | 26,100 | $32.13 | $839K | — | Form 4, Sep 30, 2022 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 12444 | Kimberly Chainey SVP, Chief Legal Officer, Veralto. Cystal Lake, IL | $6.2M |
| 12445 | Edward J. Zoiss Pres., Space & Airborne Sys., L3Harris Technologies. Melbourne, FL | $6.2M |
| 12446 | Schond Greenway Chief Financial Officer, Definium Therapeutics. New York, NY | $6.2M |
| 12447 | Richard L. Lindstrom, M.D Director, Harrow. Bedford, MA | $6.2M |
| 12448 | Timothy J. Kilpin President, Toy, Lic & Ent, Hasbro. Pawtucket, RI | $6.2M |
| 12449 | Todd W. Fister President and COO, Owens Corning. Toledo, OH | $6.2M |
| 12450 | Michael R. Leach Chief Financial Officer, Allient. Amherst, NY | $6.2M |
Other Harrow insiders
All HROW insiders- Mark L. Baum$96.3MCHIEF EXECUTIVE OFFICER. #1548 overall
- Andrew R. Boll$26.2MPRESIDENT AND CFO. #4218 overall
- John P. Saharek$15.0MCEO & President, ImprimisRx. #6437 overall
Questions
How much stock does Richard L. Lindstrom, M.D own?
Richard L. Lindstrom, M.D holds $6,221,499 in listed stock based on SEC filings and current prices, mostly Harrow (HROW). That ranks 12447th on the Stock Rich List.
Is this Richard L. Lindstrom, M.D's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Richard L. Lindstrom, M.D last buy or sell stock?
The most recent open-market trade on file is a purchase of 60,229 OCUL shares on Feb 20, 2026 at $7.66.